. Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis. IBRO Rep. 2019 Jun;6:74-86. Epub 2019 Jan 11 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.